作者:Tohru Fukuyama、Shigeru Ieda、Yusuke Asoh、Teppei Fujimoto、Haruka Kitaoka、Toshiyuki Kan
DOI:10.3987/com-08-s(d)38
日期:——
The total synthesis of potent immunosuppressant FR901483 (1) is reported. The remarkable feature of our convergent synthesis is the p-methoxybenzyl and methylamino groups are stereoselectively incorporated within the tri-cyclic core skeleton. The skeleton itself is constructed by an intramolecular aldol reaction on a symmetrical keto-aldehyde (14), which is readily derived by an eight-step sequence from nitromethane and methyl acrylate.
Stereocontrolled Total Synthesis of Potent Immunosuppressant FR901483
A total synthesis of the potent immunosuppressant FR901483 (1) has been accomplished. The key feature of our convergent synthesis is the stereoselective incorporation of the p-methoxybenzyl and methylamino groups within the core moiety 10. Tricycle 10 was itself constructed by an intramolecular aldol reaction of the symmetrical keto-aldehyde 7.
ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
申请人:Epizyme, Inc.
公开号:US20170291905A1
公开(公告)日:2017-10-12
Described herein are compounds of Formula (S-I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting arginine methyltransferase activity. Methods of using the compounds for treating arginine methyltransferase-mediated disorders are also described.